
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor Inc. is positioned for growth due to significant market share gains of $100 million stemming from recent contract renegotiations, which are expected to contribute positively to future profitability through increased fixed cost absorption. The company operates in a strong healthcare market, with potential for margin expansion to align more closely with industry peers, suggesting a favorable outlook for multiple expansion in the long term. Despite current headwinds, management's commitment to a multi-year cost-cutting program, anticipated to generate over $400 million in savings by the end of 2027, further supports a positive financial trajectory for Avantor.
Bears say
Avantor Inc. has revised its fiscal year 2025 organic revenue growth outlook downward, now expecting a range of -2% to 0% due to specific customer challenges in key bioprocessing sectors and a decline in 2Q revenue. The company's 2Q organic revenues fell by 1% to $1.58 billion, with adjusted EBITDA of $280 million missing expectations, leading to a margin shortfall compared to consensus estimates. Additionally, significant headwinds from major bioprocess customers and declining anticipated revenues in related segments indicate a challenging environment for Avantor that may prolong the negative impact on performance through 2026.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares